Literature DB >> 7752211

Correlation of six methods for typing nosocomial isolates of Acinetobacter baumannii.

M A Marcos1, M T Jimenez de Anta, J Vila.   

Abstract

A comparative study of biotyping, antimicrobial susceptibility, whole-cell protein analysis, plasmid analysis, pulsed-field gel electrophoresis of chromosomal DNA and polymerase chain reaction with arbitrary primers of Acinetobacter baumannii isolates from three large hospitals was performed to determine the best markers for epidemiological purposes. Ninety-two isolates were included: 38 belonged to a previously described outbreak and 54 were randomly selected from sporadic cases of infection. Biotyping, whole-cell protein and plasmid analysis were the least discriminatory methods, whereas antimicrobial susceptibility and polymerase chain reaction with arbitrary primers showed moderate discriminatory power. Typing based on pulsed-field gel electrophoresis of chromosomal DNA appeared to be the best discriminatory method (discrimination index of 0.9623). The addition of polymerase chain reaction with arbitrary primers or antimicrobial susceptibility to pulsed-field gel electrophoresis of chromosomal DNA did not further increase the discriminatory power.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752211     DOI: 10.1099/00222615-42-5-328

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Molecular epidemiology of acquisition of ceftazidime-resistant gram-negative bacilli in a nonoutbreak setting.

Authors:  E D'Agata; L Venkataraman; P DeGirolami; M Samore
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.

Authors:  Sara Marti; Javier Sánchez-Céspedes; M Dolores Blasco; Marc Ruiz; Paula Espinal; Verónica Alba; Felipe Fernández-Cuenca; Alvaro Pascual; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

4.  Molecular typing of Acinetobacter baumannii from ten different intensive care units of a university hospital.

Authors:  E Presterl; R Nadrchal; S Winkler; A Makristathis; W Koller; M L Rotter; A M Hirschl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

5.  Isolation of verotoxin-producing Escherichia coli O-rough:K1:H7 from two patients with traveler's diarrhea.

Authors:  J Vila; M Vargas; J Ruiz; F Gallardo; M T Jimenez de Anta; J Gascón
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

6.  Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter.

Authors:  R Pantophlet; L Brade; L Dijkshoorn; H Brade
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

7.  Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center.

Authors:  P Espinal; G Fugazza; Y López; M Kasma; Y Lerman; S Malhotra-Kumar; H Goossens; Y Carmeli; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

8.  Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.

Authors:  J Vila; J Ruiz; M Navia; B Becerril; I Garcia; S Perea; I Lopez-Hernandez; I Alamo; F Ballester; A M Planes; J Martinez-Beltran; T J de Anta
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Outbreak of nosocomial Acinetobacter baumannii bacteremia in a high risk ward.

Authors:  A Kapil; S Gulati; V Goel; L Kumar; R Krishnan; V Kochupillai
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

Review 10.  Antibiotic-Resistant Acinetobacter baumannii Increasing Success Remains a Challenge as a Nosocomial Pathogen.

Authors:  Ana Maria Gonzalez-Villoria; Veronica Valverde-Garduno
Journal:  J Pathog       Date:  2016-02-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.